Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study

被引:58
作者
Christoffersen, Mette [1 ]
Frikke-Schmidt, Ruth [1 ]
Schnohr, Peter [2 ]
Jensen, Gorm B. [2 ,3 ]
Nordestgaard, Borge G. [2 ,4 ]
Tybjaerg-Hansen, Anne [1 ,2 ]
机构
[1] Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark
[2] Bispebjerg Hosp, Copenhagen City Heart Study, DK-2400 Copenhagen, Denmark
[3] Univ Copenhagen, Hvidovre Hosp, Dept Cardiol, DK-2650 Hvidovre, Denmark
[4] Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark
来源
BMJ-BRITISH MEDICAL JOURNAL | 2011年 / 343卷
基金
英国医学研究理事会;
关键词
CARDIOVASCULAR RISK-FACTORS; CORONARY HEART-DISEASE; ANKLE-BRACHIAL INDEX; MORTALITY; ATHEROSCLEROSIS; PALPEBRARUM; ASSOCIATION; MEN;
D O I
10.1136/bmj.d5497
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To test the hypothesis that xanthelasmata and arcus corneae, individually and combined, predict risk of ischaemic vascular disease and death in the general population. Design Prospective population based cohort study. Setting The Copenhagen City Heart Study. Participants 12 745 people aged 20-93 years free of ischaemic vascular disease at baseline and followed from 1976-8 until May 2009 with 100% complete follow-up. Main outcome measures Hazard ratios for myocardial infarction, ischaemic heart disease, ischaemic stroke, ischaemic cerebrovascular disease, and death; odds ratios for severe atherosclerosis. Results 563 (4.4%) of participants had xanthelasmata and 3159 (24.8%) had arcus corneae at baseline. During 33 years' follow-up (mean 22 years), 1872 developed myocardial infarction, 3699 developed ischaemic heart disease, 1498 developed ischaemic stroke, 1815 developed ischaemic cerebrovascular disease, and 8507 died. Multifactorially adjusted hazard/odds ratios for people with versus those without xanthelasmata were 1.48 (95% confidence interval 1.23 to 1.79) for myocardial infarction, 1.39 (1.20 to 1.60) for ischaemic heart disease, 0.94 (0.73 to 1.21) for ischaemic stroke, 0.91 (0.72 to 1.15) for ischaemic cerebrovascular disease, 1.69 (1.03 to 2.79) for severe atherosclerosis, and 1.14 (1.04 to 1.26) for death. The corresponding hazard/odds ratios for people with versus those without arcus corneae were non-significant. In people with versus those without both xanthelasmata and arcus corneae, hazard/odds ratios were 1.47 (1.09 to 1.99) for myocardial infarction, 1.56 (1.25 to 1.94) for ischaemic heart disease, 0.87 (0.57 to 1.31) for ischaemic stroke, 0.86 (0.58 to 1.26) for ischaemic cerebrovascular disease, 2.75 (0.75 to 10.1) for severe atherosclerosis, and 1.09 (0.93 to 1.28) for death. In all age groups in both women and men, absolute 10 year risk of myocardial infarction, ischaemic heart disease, and death increased in the presence of xanthelasmata. The highest absolute 10 year risks of ischaemic heart disease of 53% and 41% were found in men aged 70-79 years with and without xanthelasmata. Corresponding values in women were 35% and 27%. Conclusion Xanthelasmata predict risk of myocardial infarction, ischaemic heart disease, severe atherosclerosis, and death in the general population, independently of well known cardiovascular risk factors, including plasma cholesterol and triglyceride concentrations. In contrast, arcus corneae is not an important independent predictor of risk.
引用
收藏
页数:17
相关论文
共 35 条
[1]   Myocardial infarction redefined -: A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Hoppe, U ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
de Werf, FV ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
EUROPEAN HEART JOURNAL, 2000, 21 (18) :1502-1513
[2]   XANTHELASMA - CLINICAL INDICATOR OF DECREASED LEVELS OF HIGH-DENSITY LIPOPROTEIN CHOLESTEROL [J].
BATES, MC ;
WARREN, SG .
SOUTHERN MEDICAL JOURNAL, 1989, 82 (05) :570-574
[3]   THE PATHOGENESIS AND CLINICAL-SIGNIFICANCE OF XANTHELASMA PALPEBRARUM [J].
BERGMAN, R .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 30 (02) :236-242
[4]   Xanthelasma is not associated with increased risk of carotid atherosclerosis in normolipidaemia [J].
Chan, C. -C. ;
Lin, S. -J. ;
Hwang, J. -J. ;
Sun, C. -C. ;
Jeng, J. -S. ;
Hwang, B. -S. ;
Chiu, H. -C. ;
Chen, M. -F. ;
Liau, C. -S. ;
Hsu, H. -J. ;
Su, T. -C. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (02) :221-227
[5]   MORTALITY OVER A PERIOD OF 10 YEARS IN PATIENTS WITH PERIPHERAL ARTERIAL-DISEASE [J].
CRIQUI, MH ;
LANGER, RD ;
FRONEK, A ;
FEIGELSON, HS ;
KLAUBER, MR ;
MCCANN, TJ ;
BROWNER, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (06) :381-386
[6]   INCREASED FREQUENCY OF APO E-ND PHENOTYPE AND HYPERAPOBETALIPOPROTEINEMIA IN NORMOLIPIDEMIC SUBJECTS WITH XANTHELASMAS OF THE EYELIDS [J].
DOUSTEBLAZY, P ;
MARCEL, YL ;
COHEN, L ;
GIROUX, JM ;
DAVIGNON, J .
ANNALS OF INTERNAL MEDICINE, 1982, 96 (02) :164-169
[7]   Ankle brachial index, C-reactive protein, and central augmentation index to identify individuals with severe atherosclerosis [J].
Eldrup, N ;
Sillesen, H ;
Prescott, E ;
Nordestgaard, BG .
EUROPEAN HEART JOURNAL, 2006, 27 (03) :316-322
[8]   Corneal arcus as coronary artery disease risk factor [J].
Fernandez, Antonio ;
Sorokin, Alexey ;
Thompson, Paul D. .
ATHEROSCLEROSIS, 2007, 193 (02) :235-240
[9]   Relation of Corneal Arcus to Cardiovascular Disease (from the Framingham Heart Study Data Set) [J].
Fernandez, Antonio B. ;
Keyes, Michelle J. ;
Pencina, Michael ;
D'Agostino, Ralph ;
O'Donnell, Christopher J. ;
Thompson, Paul D. .
AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (01) :64-66
[10]   Guidelines on the management of stable angina pectoris: executive summary [J].
Fox, Kim ;
Angeles Alonso Garcia, Maria ;
Ardissino, Diego ;
Buszman, Pawel ;
Katowice ;
Camici, Paolo G. ;
Crea, Filippo ;
Daly, Caroline ;
De Backer, Guy ;
Ghent ;
Hjemdahl, Paul ;
Lopez-Sendon, Jose ;
Marco, Jean ;
Morais, Joao ;
Leiria ;
Pepper, John ;
Sechtem, Udo ;
Simoons, Maarten ;
Thygesen, Kristian ;
Priori, Silvia G. ;
Blanc, Jean-Jacques ;
Budaj, Andrzej ;
Camm, John ;
Dean, Veronica ;
Deckers, Jaap ;
Dickstei, Kenneth ;
Lekakis, John ;
McGregor, Keith ;
Metra, Marco ;
Morais, Joao ;
Osterspey, Ady ;
Tamargo, Juan ;
Zamorano, Jose L. ;
Andreotti, Felicita ;
Becher, Harald ;
Dietz, Rainer ;
Fraser, Alan ;
Hernandez Antolin, Rosa Ana ;
Huber, Kurt ;
Kremastinos, Dimitris T. ;
Maseri, Attilio ;
Nesser, Hans-Joachim ;
Pasierski, Tomasz ;
Sigwart, Ulrich ;
Tubaro, Marco ;
Weis, Michael .
EUROPEAN HEART JOURNAL, 2006, 27 (11) :1341-1381